Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance-Reference-Cited by-同舟云学术

Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance

Published:2019-07-09 Issue:34 Volume:38 Page:6159-6171
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Totsch Stacie K.,Schlappi Charles,Kang Kyung-Don,Ishizuka Andrew S.^ORCID,Lynn Geoffrey M.,Fox Brandon,Beierle Elizabeth A.,Whitley Richard J.,Markert James M.,Gillespie G. Yancey,Bernstock Joshua D.,Friedman Gregory K.

Funder

U.S. Department of Health & Human Services | U.S. Food and Drug Administration

U.S. Department of Defense

Hyundai Motor Group | Hyundai Motor America | Hyundai Hope On Wheels

Rally Foundation for Childhood Cancer Research Kaul Pediatric Research Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

American Brain Tumor Association

UAB Medical Scientist Training Program

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-019-0870-y.pdf

Reference100 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.

2. Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, et al. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro Oncol. 2017;19(suppl_5):v1–88.

3. Krull KR, Hardy KK, Kahalley LS, Schuitema I, Kesler SR. Neurocognitive outcomes and interventions in long-term survivors of childhood cancer. J Clin Oncol. 2018;36:2181–9.

4. Shah AC, Benos D, Gillespie GY, Markert JM. Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas. J Neurooncol. 2003;65:203–26.

5. Friedman GK, Pressey JG, Reddy AT, Markert JM, Gillespie GY. Herpes simplex virus oncolytic therapy for pediatric malignancies. Mol Ther. 2009;17:1125–35.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Herpes simplex virus infections;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Spatial computational modelling illuminates the role of the tumour microenvironment for treating glioblastoma with immunotherapies;npj Systems Biology and Applications;2024-08-18

3. cGAS-STING pathway in systemic lupus erythematosus: biological implications and therapeutic opportunities;Immunologic Research;2024-08-03

4. Synergistic effects of herpes oncolytic virus and cyclophosphamide for recurrent malignant glioma: a narrative review;Annals of Medicine & Surgery;2024-07-17

5. Enhanced therapeutic efficacy for glioblastoma immunotherapy with an oncolytic herpes simplex virus armed with anti-PD-1 antibody and IL-12;Molecular Therapy: Oncology;2024-06